| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC 27599
* To whom correspondence should be addressed. Email: desilva{at}med.unc.edu.
| Abstract |
|---|
As dengue vaccines enter clinical trials, there is a need for rapid and quantitative assays to measure neutralization. We have developed flow-based neutralization assays, which generated similar results to the established, plaque reduction neutralization test. The flow assays are an improvement as they utilize human cells and allow for high-throughput screening.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|